Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GODAVARI DRU   TEVA PHARMA
EQUITY SHARE DATA
    GODAVARI DRU
Mar-23
TEVA PHARMA
Dec-13
GODAVARI DRU/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1023,480-   
Low Rs523,023-   
Sales per share (Unadj.) Rs212.01,997.4-  
Earnings per share (Unadj.) Rs5.0124.8-  
Cash flow per share (Unadj.) Rs7.6286.2-  
Dividends per share (Unadj.) Rs0109.23-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs44.42,218.7-  
Shares outstanding (eoy) m7.53848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.41.6 22.3%   
Avg P/E ratio x15.326.1 58.8%  
P/CF ratio (eoy) x10.111.4 89.1%  
Price / Book Value ratio x1.71.5 118.4%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m5802,757,543 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m480-   
Avg. sales/employee Rs Th037,685.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,354.2-  
INCOME DATA
Net Sales Rs m1,5961,693,781 0.1%  
Other income Rs m70-   
Total revenues Rs m1,6031,693,781 0.1%   
Gross profit Rs m102463,843 0.0%  
Depreciation Rs m19136,910 0.0%   
Interest Rs m3933,269 0.1%   
Profit before tax Rs m49293,664 0.0%   
Minority Interest Rs m01,334 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,775 -0.0%   
Tax Rs m11-3,585 -0.3%   
Profit after tax Rs m38105,809 0.0%  
Gross profit margin %6.427.4 23.2%  
Effective tax rate %23.3-1.2 -1,906.8%   
Net profit margin %2.46.2 38.0%  
BALANCE SHEET DATA
Current assets Rs m8701,143,974 0.1%   
Current liabilities Rs m737997,642 0.1%   
Net working cap to sales %8.38.6 96.4%  
Current ratio x1.21.1 102.9%  
Inventory Days Days191 1.1%  
Debtors Days Days1,32596 1,381.2%  
Net fixed assets Rs m344553,226 0.1%   
Share capital Rs m754,169 1.8%   
"Free" reserves Rs m2590-   
Net worth Rs m3341,881,470 0.0%   
Long term debt Rs m119866,068 0.0%   
Total assets Rs m1,2143,870,833 0.0%  
Interest coverage x2.39.8 23.0%   
Debt to equity ratio x0.40.5 77.7%  
Sales to assets ratio x1.30.4 300.4%   
Return on assets %6.43.6 176.8%  
Return on equity %11.35.6 201.4%  
Return on capital %19.54.9 396.1%  
Exports to sales %0.40-   
Imports to sales %60.30-   
Net fx Rs m-9560-   
CASH FLOW
From Operations Rs m132269,901 0.0%  
From Investments Rs m-86-95,637 0.1%  
From Financial Activity Rs m-38-323,765 0.0%  
Net Cashflow Rs m8-149,500 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.38 Rs / USD

Compare GODAVARI DRU With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare GODAVARI DRU With: BAJAJ HEALTHCARE  SEQUENT SCIENTIFIC  SYNCOM HEALTHCARE  ASTRAZENECA PHARMA  GUFIC BIOSCIENCE  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.